ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: NCI Should Continue Supporting Research In Special Populations

July 31, 1998

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

February 7, 1997

House Committee on Appropriations approves $28.5 billion for NIH.

June 24, 2005

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

House panel examines use of grant funds.

September 23, 2005

DeVita Recommends Carcinogenesis Testing Program Be Moved to NIEHS

May 23, 1980